- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PD-1 immunobiology in glomerulonephritis and renal cell carcinoma ; volume:22 ; number:1 ; day:6 ; month:3 ; year:2021 ; pages:1-19 ; date:12.2021
BMC nephrology ; 22, Heft 1 (6.3.2021), 1-19, 12.2021
- Creator
-
Curran, Colleen S.
Kopp, Jeffrey B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-021-02257-6
- URN
-
urn:nbn:de:101:1-2021041919213987763824
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Curran, Colleen S.
- Kopp, Jeffrey B.
- SpringerLink (Online service)
Other Objects (12)
PD-L1 expression in papillary renal cell carcinoma
Renal cell carcinoma
Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
CT findings and clinical characteristics in distinguishing renal urothelial carcinoma mimicking renal cell carcinoma from clear cell renal cell carcinoma
RARE DISTINCT SUBTYPE OF CLEAR CELL RENAL CELL CARCINOMA - MULTILOCULAR CYSTIC RENAL CELL CARCINOMA
Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy
Biology of renal cell carcinoma
CEACAM1 aggravates renal injury in heterologous glomerulonephritis
PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma
PD-L1 expression in papillary renal cell carcinoma
Renal cell carcinoma
Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
CT findings and clinical characteristics in distinguishing renal urothelial carcinoma mimicking renal cell carcinoma from clear cell renal cell carcinoma
RARE DISTINCT SUBTYPE OF CLEAR CELL RENAL CELL CARCINOMA - MULTILOCULAR CYSTIC RENAL CELL CARCINOMA
Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy
Biology of renal cell carcinoma
CEACAM1 aggravates renal injury in heterologous glomerulonephritis
PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma
PD-L1 expression in papillary renal cell carcinoma
Renal cell carcinoma
Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
CT findings and clinical characteristics in distinguishing renal urothelial carcinoma mimicking renal cell carcinoma from clear cell renal cell carcinoma
RARE DISTINCT SUBTYPE OF CLEAR CELL RENAL CELL CARCINOMA - MULTILOCULAR CYSTIC RENAL CELL CARCINOMA
Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy
Biology of renal cell carcinoma
CEACAM1 aggravates renal injury in heterologous glomerulonephritis
PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma